GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1026 - 1050 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgA Patient 1 22 moderate
G91537AT
435
IgA Patient 3 4 mild
G07483YN
435
IgA Patient 1 10 moderate
G27689OB
434
IgA Patient 1 10 moderate
G92022ML
434
IgA Patient 2 15 mild
G19118WX
434
IgA Patient 2 15 mild
G21290RB
434
IgA Patient 3 11 mild
G94576MN
434
IgA Patient 3 4 mild
G38488WF
434
IgM Patient 3 11 mild
G32699RJ
434
IgA Patient 1 10 moderate
G65889KE
433
IgA Patient 1 6 moderate
G47362BJ
433
IgA Patient 4 12 mild
G67045LB
433
IgA Patient 1 10 moderate
G00065MO
432
IgA Patient 1 10 moderate
G37036SF
432
IgA Patient 1 10 moderate
G75896PD
432
IgA Patient 1 22 moderate
G26125KY
432
IgA Patient 2 24 mild
G16579HJ
432
IgA Patient 2 3 mild
G08520NM
432
IgA Patient 3 11 mild
G08520NM
432
IgA Patient 1 10 moderate
G53168IY
431
IgA Patient 2 15 mild
G30839DN
431
IgA Patient 2 3 mild
G67045LB
431
IgG Patient 2 3 mild
G12200GB
431
IgA Patient 3 11 mild
G52880ZN
431
IgA Patient 3 4 mild
G72739GY
431

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024